HART

Harvard Apparatus Regenerative Technology CEO David Green Interviewed on Boston’s CBS-TV Affiliate on May 8

[Business Wire] – David Green, CEO of Harvard Apparatus Regenerative Technology, Inc. , a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, was interviewed by health reporter Dr. moreView todays social media effects on HARTView the latest stocks trending across Twitter. Click to view dashboardSee who Harvard is hiring next, click here to view […]

Harvard Apparatus Regenerative Technology Reports Operating Results for First Quarter Ended March 31, 2014

[Business Wire] – Harvard Apparatus Regenerative Technology, Inc. , a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea moreView todays social media effects on HARTView the latest stocks trending across Twitter. Click to view dashboardSee who Harvard is hiring next, click here to view […]

Harvard Bioscience Reports Fourth Quarter and Year-End 2013 Results

[GlobeNewswire] – HOLLISTON, Mass. — Harvard Bioscience, Inc. , a global developer, manufacturer, and marketer of a broad range of specialized products to advance life science research, today reported financial highlights … moreView todays social media effects on HARTView the latest stocks trending across Twitter. Click to view dashboardSee who Harvard is hiring next, click here to view […]

Harvard Apparatus Regenerative Technology to Present at 2nd Annual Regen Med Investor Day in New York City

[Business Wire] – Harvard Apparatus Regenerative Technology, Inc. , a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea, will present at the 2nd Annual Regen Med Investor Day in New York C moreView todays social media effects on HARTView the latest stocks trending across Twitter. Click to view dashboardSee who Harvard is hiring next, […]

Harvard Apparatus Regenerative Technology Collaboration with Texas Heart Institute Profiled by Houston’s NBC-TV Affiliate on February 19

[Business Wire] – Harvard Apparatus Regenerative Technology, Inc. , a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea moreView todays social media effects on HARTView the latest stocks trending across Twitter. Click to view dashboardSee who Harvard is hiring next, click here to view […]

Harvard Apparatus Regenerative Technology Profiled by Xconomy.com

[Business Wire] – Harvard Apparatus Regenerative Technology, Inc. , a clinical stage biotechnology company developing regenerated organs for transplant, initially focused on the trachea moreView todays social media effects on HARTView the latest stocks trending across Twitter. Click to view dashboardSee who Harvard is hiring next, click here to view […]

7 U.S. IPOs Planned For The Week Of April 8

moreView todays social media effects on HARTView the latest stocks trending across Twitter. Click to view dashboardSee who Harvard is hiring next, click here to view […]